Sponsors

Intastop’s £200,000 investment ‘driving greater efficiencies’

Intastop, a manufacturer and supplier of door and wall protective products, and anti-ligature and access, seals, and acoustic products for markets including healthcare, has recently invested £200,000 in design, manufacturing, and assembly functions.

The Doncaster-based company, with has a customer base spread throughout the UK and Europe, says the investment has seen it become self-sufficient, ‘driving greater efficiencies’. Supported by a Business Productivity Grant via the local authority and the EU, the funding has allowed the purchase of new equipment, training, tooling, new CRM/MRP systems, and a ‘manufacturing excellence programme’, which Intastop says 'will drive an increased turnover ahead of further strategic growth plans'. 

Over the next five years Intastop plans to expand its product range of door, wall, and ‘people protection’ products, through ongoing R&D, and says it 'continues to support the healthcare, leisure, public building, and mental health sectors'. With a firm foothold in mental healthcare ‘solutions’ in the UK, it also plans to roll out its export strategy to international markets.

“This investment heralds the next chapter in Intastop’s history, and is already delivering a significant positive impact on the way the business operates,” explained MD, Steve Woodhead (pictured). “No longer need we rely on a supplier based outside the UK, which didn’t really fit with our vision and business strategy. This was the catalyst for the investment, and has removed a lengthy supply chain process, and allowed us to bring the business to Yorkshire.

 “Our vision for continuous improvement and growth has seen us increase turnover by 60% in the last five years, and this change in direction will allow us to capitalise on this further. Over the years we have shifted from a business heavily weighted towards warehousing and distribution to one driving forward innovation, design, and investment – not only in our business, but in the wider healthcare and anti-ligature market.”

 

Latest Issue